UBS Group
RCPI

UBS Group’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

UBS Group’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,362
Closed -$2K – 8954
2015
Q3 		$2K Buy
2,362
+139
+6% +$155 ﹤0.01% 8161
2015
Q2 		$3K Sell
2,223
-251
-10% -$598 ﹤0.01% 8146
2015
Q1 		$7K Buy
2,474
+1,698
+219% +$6.68K ﹤0.01% 7971
2014
Q4 		$4K Buy
+776
New +$4.08K ﹤0.01% 9187

Other funds holding RCPI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
WP
WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return
IWMPD
Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.85% 1-Year Est. Return

UBS Group's RCPI Position: Q4 2015 in Review

UBS Group sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 2,362 shares — an estimated $2K sold.

UBS Group first reported a position in RCPI in Q4 2014 and held it in 4 quarters. The position peaked at $7K in Q1 2015. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

  • UBS Group reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • UBS Group sold 2,362 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015, an estimated $2K.
  • UBS Group first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 4 quarters.
  • UBS Group's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $7K in Q1 2015.
  • 9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on UBS Group's 13F filing for Q4 2015, filed 16 Feb 2016.